-- Given Rises to 5-Month High as Patients Enroll in Pillcam Trial
-- B y   S h o s h a n n a   S o l o m o n
-- 2012-01-04T13:52:49Z
-- http://www.bloomberg.com/news/2012-01-04/given-rises-to-5-month-high-as-patients-enroll-in-pillcam-trial.html
Given Imaging Ltd. (GIVN)  advanced to the
highest in more than five months after the maker of a pill-sized
camera to diagnose digestive ailments said about 700 patients
have enrolled in a PillCam COLON 2 trial.  The  shares gained (GIVN)  2.2 percent to 69.21 shekels, the highest
intraday level since July 27, at 3:48 p.m. in  Tel Aviv .  To contact the reporter on this story:
Shoshanna Solomon in Tel Aviv at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  